nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—SLC16A1—Methotrexate—urinary bladder cancer	0.0575	0.0812	CbGbCtD
Pravastatin—SLC22A7—Fluorouracil—urinary bladder cancer	0.0512	0.0724	CbGbCtD
Pravastatin—ABCB1—Mitomycin—urinary bladder cancer	0.0394	0.0557	CbGbCtD
Pravastatin—ABCB11—Doxorubicin—urinary bladder cancer	0.0322	0.0456	CbGbCtD
Pravastatin—SLCO1B3—Methotrexate—urinary bladder cancer	0.0321	0.0454	CbGbCtD
Pravastatin—SLC22A11—Methotrexate—urinary bladder cancer	0.0297	0.0419	CbGbCtD
Pravastatin—ABCC2—Carboplatin—urinary bladder cancer	0.0296	0.0418	CbGbCtD
Pravastatin—SLC22A7—Methotrexate—urinary bladder cancer	0.0283	0.0399	CbGbCtD
Pravastatin—ABCG2—Fluorouracil—urinary bladder cancer	0.0269	0.0381	CbGbCtD
Pravastatin—ABCG2—Carboplatin—urinary bladder cancer	0.0268	0.0378	CbGbCtD
Pravastatin—ABCC2—Cisplatin—urinary bladder cancer	0.0253	0.0358	CbGbCtD
Pravastatin—ABCC2—Etoposide—urinary bladder cancer	0.0249	0.0351	CbGbCtD
Pravastatin—ABCG2—Cisplatin—urinary bladder cancer	0.0229	0.0323	CbGbCtD
Pravastatin—ABCG2—Etoposide—urinary bladder cancer	0.0225	0.0318	CbGbCtD
Pravastatin—SLCO1A2—Methotrexate—urinary bladder cancer	0.0198	0.028	CbGbCtD
Pravastatin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0187	0.0264	CbGbCtD
Pravastatin—CYP3A4—Thiotepa—urinary bladder cancer	0.0179	0.0253	CbGbCtD
Pravastatin—SLC22A8—Methotrexate—urinary bladder cancer	0.0172	0.0244	CbGbCtD
Pravastatin—ABCC2—Doxorubicin—urinary bladder cancer	0.017	0.024	CbGbCtD
Pravastatin—ABCC2—Methotrexate—urinary bladder cancer	0.0164	0.0232	CbGbCtD
Pravastatin—ABCG2—Doxorubicin—urinary bladder cancer	0.0153	0.0217	CbGbCtD
Pravastatin—ABCG2—Methotrexate—urinary bladder cancer	0.0148	0.021	CbGbCtD
Pravastatin—CYP2C8—Fluorouracil—urinary bladder cancer	0.0143	0.0203	CbGbCtD
Pravastatin—CYP3A5—Etoposide—urinary bladder cancer	0.0124	0.0176	CbGbCtD
Pravastatin—SLC22A6—Methotrexate—urinary bladder cancer	0.012	0.017	CbGbCtD
Pravastatin—CYP2C8—Etoposide—urinary bladder cancer	0.012	0.0169	CbGbCtD
Pravastatin—ABCB1—Gemcitabine—urinary bladder cancer	0.0113	0.016	CbGbCtD
Pravastatin—CYP2C9—Fluorouracil—urinary bladder cancer	0.01	0.0141	CbGbCtD
Pravastatin—CYP2C9—Cisplatin—urinary bladder cancer	0.0085	0.012	CbGbCtD
Pravastatin—ABCB1—Cisplatin—urinary bladder cancer	0.00825	0.0117	CbGbCtD
Pravastatin—ABCB1—Etoposide—urinary bladder cancer	0.0081	0.0115	CbGbCtD
Pravastatin—ABCB1—Doxorubicin—urinary bladder cancer	0.00553	0.00781	CbGbCtD
Pravastatin—ABCB1—Methotrexate—urinary bladder cancer	0.00535	0.00757	CbGbCtD
Pravastatin—CYP2D6—Doxorubicin—urinary bladder cancer	0.00521	0.00736	CbGbCtD
Pravastatin—CYP3A4—Etoposide—urinary bladder cancer	0.00485	0.00686	CbGbCtD
Pravastatin—Simvastatin—UGT2B7—urinary bladder cancer	0.00382	0.506	CrCbGaD
Pravastatin—Lovastatin—UGT2B7—urinary bladder cancer	0.00374	0.495	CrCbGaD
Pravastatin—SLC22A8—urine—urinary bladder cancer	0.00372	0.0663	CbGeAlD
Pravastatin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00331	0.00468	CbGbCtD
Pravastatin—CYP2C9—urine—urinary bladder cancer	0.00242	0.0431	CbGeAlD
Pravastatin—CYP3A4—urine—urinary bladder cancer	0.00184	0.0328	CbGeAlD
Pravastatin—CYP2D6—urine—urinary bladder cancer	0.00181	0.0323	CbGeAlD
Pravastatin—HMGCR—prostate gland—urinary bladder cancer	0.00179	0.032	CbGeAlD
Pravastatin—SLC16A1—prostate gland—urinary bladder cancer	0.00177	0.0315	CbGeAlD
Pravastatin—SLC22A11—renal system—urinary bladder cancer	0.00161	0.0287	CbGeAlD
Pravastatin—SLC22A7—renal system—urinary bladder cancer	0.00157	0.0281	CbGeAlD
Pravastatin—SLCO2B1—prostate gland—urinary bladder cancer	0.00152	0.0271	CbGeAlD
Pravastatin—HMGCR—seminal vesicle—urinary bladder cancer	0.00152	0.027	CbGeAlD
Pravastatin—SLCO1B3—vagina—urinary bladder cancer	0.00147	0.0261	CbGeAlD
Pravastatin—SLC22A8—prostate gland—urinary bladder cancer	0.00134	0.0238	CbGeAlD
Pravastatin—HMGCR—epithelium—urinary bladder cancer	0.00132	0.0235	CbGeAlD
Pravastatin—ABCC2—prostate gland—urinary bladder cancer	0.0013	0.0232	CbGeAlD
Pravastatin—SLC16A1—epithelium—urinary bladder cancer	0.0013	0.0231	CbGeAlD
Pravastatin—SLC22A11—female reproductive system—urinary bladder cancer	0.00129	0.023	CbGeAlD
Pravastatin—HMGCR—smooth muscle tissue—urinary bladder cancer	0.00127	0.0226	CbGeAlD
Pravastatin—HMGCR—renal system—urinary bladder cancer	0.00122	0.0218	CbGeAlD
Pravastatin—SLC16A1—renal system—urinary bladder cancer	0.0012	0.0215	CbGeAlD
Pravastatin—HMGCR—urethra—urinary bladder cancer	0.0012	0.0214	CbGeAlD
Pravastatin—SLCO1B1—renal system—urinary bladder cancer	0.00117	0.0209	CbGeAlD
Pravastatin—SLCO2B1—renal system—urinary bladder cancer	0.00104	0.0185	CbGeAlD
Pravastatin—HMGCR—female reproductive system—urinary bladder cancer	0.000979	0.0174	CbGeAlD
Pravastatin—SLC16A1—female reproductive system—urinary bladder cancer	0.000964	0.0172	CbGeAlD
Pravastatin—SLCO1A2—renal system—urinary bladder cancer	0.000953	0.017	CbGeAlD
Pravastatin—ABCG2—prostate gland—urinary bladder cancer	0.00095	0.0169	CbGeAlD
Pravastatin—SLCO1B1—female reproductive system—urinary bladder cancer	0.000938	0.0167	CbGeAlD
Pravastatin—SLC22A8—renal system—urinary bladder cancer	0.00091	0.0162	CbGeAlD
Pravastatin—ABCC2—renal system—urinary bladder cancer	0.000888	0.0158	CbGeAlD
Pravastatin—HMGCR—vagina—urinary bladder cancer	0.000886	0.0158	CbGeAlD
Pravastatin—CYP3A5—prostate gland—urinary bladder cancer	0.000882	0.0157	CbGeAlD
Pravastatin—SLCO2B1—female reproductive system—urinary bladder cancer	0.00083	0.0148	CbGeAlD
Pravastatin—ABCG2—seminal vesicle—urinary bladder cancer	0.000804	0.0143	CbGeAlD
Pravastatin—ABCC2—female reproductive system—urinary bladder cancer	0.000711	0.0127	CbGeAlD
Pravastatin—CYP2C8—renal system—urinary bladder cancer	0.000666	0.0119	CbGeAlD
Pravastatin—ABCG2—urethra—urinary bladder cancer	0.000636	0.0113	CbGeAlD
Pravastatin—CYP3A5—renal system—urinary bladder cancer	0.000601	0.0107	CbGeAlD
Pravastatin—HMGCR—lymph node—urinary bladder cancer	0.000573	0.0102	CbGeAlD
Pravastatin—SLC16A1—lymph node—urinary bladder cancer	0.000564	0.0101	CbGeAlD
Pravastatin—CYP2C8—female reproductive system—urinary bladder cancer	0.000533	0.0095	CbGeAlD
Pravastatin—SLCO2B1—lymph node—urinary bladder cancer	0.000485	0.00865	CbGeAlD
Pravastatin—CYP2C8—vagina—urinary bladder cancer	0.000482	0.00859	CbGeAlD
Pravastatin—CYP2C9—female reproductive system—urinary bladder cancer	0.000474	0.00844	CbGeAlD
Pravastatin—ABCG2—vagina—urinary bladder cancer	0.000469	0.00836	CbGeAlD
Pravastatin—ABCB1—prostate gland—urinary bladder cancer	0.000469	0.00835	CbGeAlD
Pravastatin—CYP3A4—renal system—urinary bladder cancer	0.000451	0.00804	CbGeAlD
Pravastatin—CYP2D6—renal system—urinary bladder cancer	0.000444	0.00791	CbGeAlD
Pravastatin—CYP3A5—vagina—urinary bladder cancer	0.000435	0.00776	CbGeAlD
Pravastatin—ABCC2—lymph node—urinary bladder cancer	0.000416	0.00741	CbGeAlD
Pravastatin—ABCB1—seminal vesicle—urinary bladder cancer	0.000396	0.00706	CbGeAlD
Pravastatin—CYP3A4—female reproductive system—urinary bladder cancer	0.000361	0.00644	CbGeAlD
Pravastatin—CYP2D6—female reproductive system—urinary bladder cancer	0.000356	0.00633	CbGeAlD
Pravastatin—ABCB1—epithelium—urinary bladder cancer	0.000344	0.00613	CbGeAlD
Pravastatin—ABCB1—renal system—urinary bladder cancer	0.000319	0.00569	CbGeAlD
Pravastatin—ABCB1—urethra—urinary bladder cancer	0.000314	0.00559	CbGeAlD
Pravastatin—ABCG2—lymph node—urinary bladder cancer	0.000303	0.00541	CbGeAlD
Pravastatin—ABCB1—female reproductive system—urinary bladder cancer	0.000256	0.00456	CbGeAlD
Pravastatin—ABCB1—vagina—urinary bladder cancer	0.000231	0.00412	CbGeAlD
Pravastatin—Dizziness—Thiotepa—urinary bladder cancer	0.000153	0.00102	CcSEcCtD
Pravastatin—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000152	0.00102	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000152	0.00102	CcSEcCtD
Pravastatin—Urticaria—Fluorouracil—urinary bladder cancer	0.000152	0.00102	CcSEcCtD
Pravastatin—Influenza—Doxorubicin—urinary bladder cancer	0.000151	0.00101	CcSEcCtD
Pravastatin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000151	0.00101	CcSEcCtD
Pravastatin—ABCB1—lymph node—urinary bladder cancer	0.00015	0.00267	CbGeAlD
Pravastatin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00015	0.001	CcSEcCtD
Pravastatin—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000149	0.000999	CcSEcCtD
Pravastatin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000149	0.000999	CcSEcCtD
Pravastatin—Paraesthesia—Etoposide—urinary bladder cancer	0.000149	0.000997	CcSEcCtD
Pravastatin—Weight increased—Epirubicin—urinary bladder cancer	0.000149	0.000996	CcSEcCtD
Pravastatin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000148	0.000993	CcSEcCtD
Pravastatin—Weight decreased—Epirubicin—urinary bladder cancer	0.000148	0.00099	CcSEcCtD
Pravastatin—Dyspnoea—Etoposide—urinary bladder cancer	0.000148	0.00099	CcSEcCtD
Pravastatin—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000147	0.000987	CcSEcCtD
Pravastatin—Vomiting—Thiotepa—urinary bladder cancer	0.000147	0.000983	CcSEcCtD
Pravastatin—Rash—Thiotepa—urinary bladder cancer	0.000145	0.000975	CcSEcCtD
Pravastatin—Dermatitis—Thiotepa—urinary bladder cancer	0.000145	0.000974	CcSEcCtD
Pravastatin—Headache—Thiotepa—urinary bladder cancer	0.000144	0.000968	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000144	0.000968	CcSEcCtD
Pravastatin—Decreased appetite—Etoposide—urinary bladder cancer	0.000144	0.000965	CcSEcCtD
Pravastatin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000143	0.000958	CcSEcCtD
Pravastatin—Fatigue—Etoposide—urinary bladder cancer	0.000143	0.000957	CcSEcCtD
Pravastatin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000143	0.000957	CcSEcCtD
Pravastatin—Jaundice—Epirubicin—urinary bladder cancer	0.000142	0.000951	CcSEcCtD
Pravastatin—Pain—Etoposide—urinary bladder cancer	0.000142	0.00095	CcSEcCtD
Pravastatin—Constipation—Etoposide—urinary bladder cancer	0.000142	0.00095	CcSEcCtD
Pravastatin—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000142	0.000949	CcSEcCtD
Pravastatin—Dysuria—Doxorubicin—urinary bladder cancer	0.000141	0.000947	CcSEcCtD
Pravastatin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000141	0.000942	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00014	0.000941	CcSEcCtD
Pravastatin—Hepatitis—Methotrexate—urinary bladder cancer	0.00014	0.000936	CcSEcCtD
Pravastatin—Asthenia—Gemcitabine—urinary bladder cancer	0.000139	0.000933	CcSEcCtD
Pravastatin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000139	0.000929	CcSEcCtD
Pravastatin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000138	0.000924	CcSEcCtD
Pravastatin—Weight increased—Doxorubicin—urinary bladder cancer	0.000138	0.000922	CcSEcCtD
Pravastatin—Pruritus—Gemcitabine—urinary bladder cancer	0.000137	0.00092	CcSEcCtD
Pravastatin—Nausea—Thiotepa—urinary bladder cancer	0.000137	0.000918	CcSEcCtD
Pravastatin—Weight decreased—Doxorubicin—urinary bladder cancer	0.000137	0.000916	CcSEcCtD
Pravastatin—Sinusitis—Epirubicin—urinary bladder cancer	0.000137	0.000916	CcSEcCtD
Pravastatin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000137	0.000915	CcSEcCtD
Pravastatin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000135	0.000908	CcSEcCtD
Pravastatin—Pruritus—Fluorouracil—urinary bladder cancer	0.000135	0.000905	CcSEcCtD
Pravastatin—Visual impairment—Methotrexate—urinary bladder cancer	0.000135	0.000902	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000134	0.000895	CcSEcCtD
Pravastatin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000133	0.000893	CcSEcCtD
Pravastatin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000133	0.00089	CcSEcCtD
Pravastatin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000132	0.000885	CcSEcCtD
Pravastatin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000132	0.000885	CcSEcCtD
Pravastatin—Urticaria—Etoposide—urinary bladder cancer	0.000132	0.000882	CcSEcCtD
Pravastatin—Jaundice—Doxorubicin—urinary bladder cancer	0.000131	0.00088	CcSEcCtD
Pravastatin—Rhinitis—Epirubicin—urinary bladder cancer	0.000131	0.000878	CcSEcCtD
Pravastatin—Abdominal pain—Etoposide—urinary bladder cancer	0.000131	0.000878	CcSEcCtD
Pravastatin—Body temperature increased—Etoposide—urinary bladder cancer	0.000131	0.000878	CcSEcCtD
Pravastatin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000131	0.000878	CcSEcCtD
Pravastatin—Hepatitis—Epirubicin—urinary bladder cancer	0.000131	0.000876	CcSEcCtD
Pravastatin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000131	0.000875	CcSEcCtD
Pravastatin—Tinnitus—Methotrexate—urinary bladder cancer	0.00013	0.000873	CcSEcCtD
Pravastatin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00013	0.000872	CcSEcCtD
Pravastatin—Asthenia—Cisplatin—urinary bladder cancer	0.00013	0.00087	CcSEcCtD
Pravastatin—Pharyngitis—Epirubicin—urinary bladder cancer	0.00013	0.00087	CcSEcCtD
Pravastatin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00013	0.000869	CcSEcCtD
Pravastatin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000126	0.000847	CcSEcCtD
Pravastatin—Dizziness—Fluorouracil—urinary bladder cancer	0.000126	0.000845	CcSEcCtD
Pravastatin—Visual impairment—Epirubicin—urinary bladder cancer	0.000126	0.000844	CcSEcCtD
Pravastatin—Chills—Methotrexate—urinary bladder cancer	0.000125	0.00084	CcSEcCtD
Pravastatin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000124	0.000829	CcSEcCtD
Pravastatin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000124	0.000828	CcSEcCtD
Pravastatin—Alopecia—Methotrexate—urinary bladder cancer	0.000123	0.000827	CcSEcCtD
Pravastatin—Vomiting—Gemcitabine—urinary bladder cancer	0.000123	0.000827	CcSEcCtD
Pravastatin—Rash—Gemcitabine—urinary bladder cancer	0.000122	0.00082	CcSEcCtD
Pravastatin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000122	0.000819	CcSEcCtD
Pravastatin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000122	0.000818	CcSEcCtD
Pravastatin—Tinnitus—Epirubicin—urinary bladder cancer	0.000122	0.000817	CcSEcCtD
Pravastatin—Headache—Gemcitabine—urinary bladder cancer	0.000122	0.000815	CcSEcCtD
Pravastatin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000121	0.000813	CcSEcCtD
Pravastatin—Flushing—Epirubicin—urinary bladder cancer	0.000121	0.000813	CcSEcCtD
Pravastatin—Vomiting—Fluorouracil—urinary bladder cancer	0.000121	0.000813	CcSEcCtD
Pravastatin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000121	0.000813	CcSEcCtD
Pravastatin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000121	0.000811	CcSEcCtD
Pravastatin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00012	0.000807	CcSEcCtD
Pravastatin—Rash—Fluorouracil—urinary bladder cancer	0.00012	0.000806	CcSEcCtD
Pravastatin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00012	0.000805	CcSEcCtD
Pravastatin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00012	0.000805	CcSEcCtD
Pravastatin—Headache—Fluorouracil—urinary bladder cancer	0.00012	0.000801	CcSEcCtD
Pravastatin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000119	0.000798	CcSEcCtD
Pravastatin—Asthenia—Etoposide—urinary bladder cancer	0.000119	0.000797	CcSEcCtD
Pravastatin—Chills—Epirubicin—urinary bladder cancer	0.000117	0.000786	CcSEcCtD
Pravastatin—Pruritus—Etoposide—urinary bladder cancer	0.000117	0.000786	CcSEcCtD
Pravastatin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000117	0.000783	CcSEcCtD
Pravastatin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000117	0.000781	CcSEcCtD
Pravastatin—Alopecia—Epirubicin—urinary bladder cancer	0.000116	0.000774	CcSEcCtD
Pravastatin—Nausea—Gemcitabine—urinary bladder cancer	0.000115	0.000772	CcSEcCtD
Pravastatin—Vomiting—Cisplatin—urinary bladder cancer	0.000115	0.000771	CcSEcCtD
Pravastatin—Vision blurred—Methotrexate—urinary bladder cancer	0.000115	0.000768	CcSEcCtD
Pravastatin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000114	0.000766	CcSEcCtD
Pravastatin—Rash—Cisplatin—urinary bladder cancer	0.000114	0.000764	CcSEcCtD
Pravastatin—Dermatitis—Cisplatin—urinary bladder cancer	0.000114	0.000764	CcSEcCtD
Pravastatin—Diarrhoea—Etoposide—urinary bladder cancer	0.000113	0.00076	CcSEcCtD
Pravastatin—Nausea—Fluorouracil—urinary bladder cancer	0.000113	0.000759	CcSEcCtD
Pravastatin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000113	0.000756	CcSEcCtD
Pravastatin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000113	0.000756	CcSEcCtD
Pravastatin—Anaemia—Methotrexate—urinary bladder cancer	0.000112	0.000753	CcSEcCtD
Pravastatin—Flushing—Doxorubicin—urinary bladder cancer	0.000112	0.000752	CcSEcCtD
Pravastatin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000112	0.000752	CcSEcCtD
Pravastatin—Flatulence—Epirubicin—urinary bladder cancer	0.000112	0.000752	CcSEcCtD
Pravastatin—Tension—Epirubicin—urinary bladder cancer	0.000112	0.000748	CcSEcCtD
Pravastatin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000111	0.000747	CcSEcCtD
Pravastatin—Nervousness—Epirubicin—urinary bladder cancer	0.000111	0.000741	CcSEcCtD
Pravastatin—Malaise—Methotrexate—urinary bladder cancer	0.00011	0.000735	CcSEcCtD
Pravastatin—Dizziness—Etoposide—urinary bladder cancer	0.00011	0.000734	CcSEcCtD
Pravastatin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000109	0.000733	CcSEcCtD
Pravastatin—Vertigo—Methotrexate—urinary bladder cancer	0.000109	0.000732	CcSEcCtD
Pravastatin—Leukopenia—Methotrexate—urinary bladder cancer	0.000109	0.000729	CcSEcCtD
Pravastatin—Chills—Doxorubicin—urinary bladder cancer	0.000109	0.000727	CcSEcCtD
Pravastatin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000108	0.000724	CcSEcCtD
Pravastatin—Nausea—Cisplatin—urinary bladder cancer	0.000107	0.00072	CcSEcCtD
Pravastatin—Vision blurred—Epirubicin—urinary bladder cancer	0.000107	0.000719	CcSEcCtD
Pravastatin—Alopecia—Doxorubicin—urinary bladder cancer	0.000107	0.000716	CcSEcCtD
Pravastatin—Cough—Methotrexate—urinary bladder cancer	0.000106	0.000711	CcSEcCtD
Pravastatin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000106	0.000708	CcSEcCtD
Pravastatin—Vomiting—Etoposide—urinary bladder cancer	0.000105	0.000706	CcSEcCtD
Pravastatin—Anaemia—Epirubicin—urinary bladder cancer	0.000105	0.000705	CcSEcCtD
Pravastatin—Rash—Etoposide—urinary bladder cancer	0.000104	0.0007	CcSEcCtD
Pravastatin—Dermatitis—Etoposide—urinary bladder cancer	0.000104	0.000699	CcSEcCtD
Pravastatin—Headache—Etoposide—urinary bladder cancer	0.000104	0.000696	CcSEcCtD
Pravastatin—Flatulence—Doxorubicin—urinary bladder cancer	0.000104	0.000695	CcSEcCtD
Pravastatin—Chest pain—Methotrexate—urinary bladder cancer	0.000104	0.000694	CcSEcCtD
Pravastatin—Arthralgia—Methotrexate—urinary bladder cancer	0.000104	0.000694	CcSEcCtD
Pravastatin—Myalgia—Methotrexate—urinary bladder cancer	0.000104	0.000694	CcSEcCtD
Pravastatin—Tension—Doxorubicin—urinary bladder cancer	0.000103	0.000692	CcSEcCtD
Pravastatin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000103	0.000691	CcSEcCtD
Pravastatin—Malaise—Epirubicin—urinary bladder cancer	0.000103	0.000688	CcSEcCtD
Pravastatin—Discomfort—Methotrexate—urinary bladder cancer	0.000102	0.000686	CcSEcCtD
Pravastatin—Nervousness—Doxorubicin—urinary bladder cancer	0.000102	0.000685	CcSEcCtD
Pravastatin—Vertigo—Epirubicin—urinary bladder cancer	0.000102	0.000685	CcSEcCtD
Pravastatin—Leukopenia—Epirubicin—urinary bladder cancer	0.000102	0.000683	CcSEcCtD
Pravastatin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000101	0.000678	CcSEcCtD
Pravastatin—Confusional state—Methotrexate—urinary bladder cancer	0.0001	0.000671	CcSEcCtD
Pravastatin—Cough—Epirubicin—urinary bladder cancer	9.93e-05	0.000666	CcSEcCtD
Pravastatin—Anaphylactic shock—Methotrexate—urinary bladder cancer	9.92e-05	0.000665	CcSEcCtD
Pravastatin—Vision blurred—Doxorubicin—urinary bladder cancer	9.92e-05	0.000665	CcSEcCtD
Pravastatin—Infection—Methotrexate—urinary bladder cancer	9.86e-05	0.000661	CcSEcCtD
Pravastatin—Nausea—Etoposide—urinary bladder cancer	9.84e-05	0.00066	CcSEcCtD
Pravastatin—Hypertension—Epirubicin—urinary bladder cancer	9.82e-05	0.000658	CcSEcCtD
Pravastatin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	9.77e-05	0.000655	CcSEcCtD
Pravastatin—Anaemia—Doxorubicin—urinary bladder cancer	9.73e-05	0.000652	CcSEcCtD
Pravastatin—Thrombocytopenia—Methotrexate—urinary bladder cancer	9.72e-05	0.000651	CcSEcCtD
Pravastatin—Myalgia—Epirubicin—urinary bladder cancer	9.69e-05	0.000649	CcSEcCtD
Pravastatin—Chest pain—Epirubicin—urinary bladder cancer	9.69e-05	0.000649	CcSEcCtD
Pravastatin—Arthralgia—Epirubicin—urinary bladder cancer	9.69e-05	0.000649	CcSEcCtD
Pravastatin—Anxiety—Epirubicin—urinary bladder cancer	9.65e-05	0.000647	CcSEcCtD
Pravastatin—Hyperhidrosis—Methotrexate—urinary bladder cancer	9.59e-05	0.000643	CcSEcCtD
Pravastatin—Discomfort—Epirubicin—urinary bladder cancer	9.57e-05	0.000642	CcSEcCtD
Pravastatin—Malaise—Doxorubicin—urinary bladder cancer	9.49e-05	0.000636	CcSEcCtD
Pravastatin—Vertigo—Doxorubicin—urinary bladder cancer	9.46e-05	0.000634	CcSEcCtD
Pravastatin—Anorexia—Methotrexate—urinary bladder cancer	9.46e-05	0.000634	CcSEcCtD
Pravastatin—Leukopenia—Doxorubicin—urinary bladder cancer	9.42e-05	0.000632	CcSEcCtD
Pravastatin—Confusional state—Epirubicin—urinary bladder cancer	9.36e-05	0.000628	CcSEcCtD
Pravastatin—Anaphylactic shock—Epirubicin—urinary bladder cancer	9.29e-05	0.000622	CcSEcCtD
Pravastatin—Oedema—Epirubicin—urinary bladder cancer	9.29e-05	0.000622	CcSEcCtD
Pravastatin—Infection—Epirubicin—urinary bladder cancer	9.23e-05	0.000618	CcSEcCtD
Pravastatin—Cough—Doxorubicin—urinary bladder cancer	9.19e-05	0.000616	CcSEcCtD
Pravastatin—Thrombocytopenia—Epirubicin—urinary bladder cancer	9.09e-05	0.000609	CcSEcCtD
Pravastatin—Hypertension—Doxorubicin—urinary bladder cancer	9.09e-05	0.000609	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	9.04e-05	0.000606	CcSEcCtD
Pravastatin—Hyperhidrosis—Epirubicin—urinary bladder cancer	8.98e-05	0.000602	CcSEcCtD
Pravastatin—Insomnia—Methotrexate—urinary bladder cancer	8.98e-05	0.000602	CcSEcCtD
Pravastatin—Arthralgia—Doxorubicin—urinary bladder cancer	8.96e-05	0.000601	CcSEcCtD
Pravastatin—Myalgia—Doxorubicin—urinary bladder cancer	8.96e-05	0.000601	CcSEcCtD
Pravastatin—Chest pain—Doxorubicin—urinary bladder cancer	8.96e-05	0.000601	CcSEcCtD
Pravastatin—Anxiety—Doxorubicin—urinary bladder cancer	8.93e-05	0.000599	CcSEcCtD
Pravastatin—Paraesthesia—Methotrexate—urinary bladder cancer	8.91e-05	0.000597	CcSEcCtD
Pravastatin—Discomfort—Doxorubicin—urinary bladder cancer	8.86e-05	0.000594	CcSEcCtD
Pravastatin—Anorexia—Epirubicin—urinary bladder cancer	8.85e-05	0.000593	CcSEcCtD
Pravastatin—Dyspnoea—Methotrexate—urinary bladder cancer	8.85e-05	0.000593	CcSEcCtD
Pravastatin—Dyspepsia—Methotrexate—urinary bladder cancer	8.74e-05	0.000585	CcSEcCtD
Pravastatin—Confusional state—Doxorubicin—urinary bladder cancer	8.66e-05	0.000581	CcSEcCtD
Pravastatin—Decreased appetite—Methotrexate—urinary bladder cancer	8.63e-05	0.000578	CcSEcCtD
Pravastatin—Oedema—Doxorubicin—urinary bladder cancer	8.59e-05	0.000576	CcSEcCtD
Pravastatin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	8.59e-05	0.000576	CcSEcCtD
Pravastatin—Fatigue—Methotrexate—urinary bladder cancer	8.56e-05	0.000573	CcSEcCtD
Pravastatin—Infection—Doxorubicin—urinary bladder cancer	8.54e-05	0.000572	CcSEcCtD
Pravastatin—Pain—Methotrexate—urinary bladder cancer	8.49e-05	0.000569	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	8.46e-05	0.000567	CcSEcCtD
Pravastatin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	8.41e-05	0.000564	CcSEcCtD
Pravastatin—Insomnia—Epirubicin—urinary bladder cancer	8.4e-05	0.000563	CcSEcCtD
Pravastatin—Paraesthesia—Epirubicin—urinary bladder cancer	8.34e-05	0.000559	CcSEcCtD
Pravastatin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	8.31e-05	0.000557	CcSEcCtD
Pravastatin—Dyspnoea—Epirubicin—urinary bladder cancer	8.28e-05	0.000555	CcSEcCtD
Pravastatin—Anorexia—Doxorubicin—urinary bladder cancer	8.19e-05	0.000549	CcSEcCtD
Pravastatin—Feeling abnormal—Methotrexate—urinary bladder cancer	8.18e-05	0.000548	CcSEcCtD
Pravastatin—Dyspepsia—Epirubicin—urinary bladder cancer	8.17e-05	0.000548	CcSEcCtD
Pravastatin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.11e-05	0.000544	CcSEcCtD
Pravastatin—Decreased appetite—Epirubicin—urinary bladder cancer	8.07e-05	0.000541	CcSEcCtD
Pravastatin—Fatigue—Epirubicin—urinary bladder cancer	8.01e-05	0.000537	CcSEcCtD
Pravastatin—Pain—Epirubicin—urinary bladder cancer	7.94e-05	0.000532	CcSEcCtD
Pravastatin—Constipation—Epirubicin—urinary bladder cancer	7.94e-05	0.000532	CcSEcCtD
Pravastatin—Urticaria—Methotrexate—urinary bladder cancer	7.88e-05	0.000528	CcSEcCtD
Pravastatin—Abdominal pain—Methotrexate—urinary bladder cancer	7.84e-05	0.000526	CcSEcCtD
Pravastatin—Body temperature increased—Methotrexate—urinary bladder cancer	7.84e-05	0.000526	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.83e-05	0.000525	CcSEcCtD
Pravastatin—Insomnia—Doxorubicin—urinary bladder cancer	7.77e-05	0.000521	CcSEcCtD
Pravastatin—Paraesthesia—Doxorubicin—urinary bladder cancer	7.72e-05	0.000517	CcSEcCtD
Pravastatin—Dyspnoea—Doxorubicin—urinary bladder cancer	7.66e-05	0.000513	CcSEcCtD
Pravastatin—Feeling abnormal—Epirubicin—urinary bladder cancer	7.65e-05	0.000513	CcSEcCtD
Pravastatin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	7.59e-05	0.000509	CcSEcCtD
Pravastatin—Dyspepsia—Doxorubicin—urinary bladder cancer	7.56e-05	0.000507	CcSEcCtD
Pravastatin—Decreased appetite—Doxorubicin—urinary bladder cancer	7.47e-05	0.000501	CcSEcCtD
Pravastatin—Fatigue—Doxorubicin—urinary bladder cancer	7.41e-05	0.000497	CcSEcCtD
Pravastatin—Urticaria—Epirubicin—urinary bladder cancer	7.38e-05	0.000494	CcSEcCtD
Pravastatin—Constipation—Doxorubicin—urinary bladder cancer	7.35e-05	0.000493	CcSEcCtD
Pravastatin—Pain—Doxorubicin—urinary bladder cancer	7.35e-05	0.000493	CcSEcCtD
Pravastatin—Abdominal pain—Epirubicin—urinary bladder cancer	7.34e-05	0.000492	CcSEcCtD
Pravastatin—Body temperature increased—Epirubicin—urinary bladder cancer	7.34e-05	0.000492	CcSEcCtD
Pravastatin—Hypersensitivity—Methotrexate—urinary bladder cancer	7.31e-05	0.00049	CcSEcCtD
Pravastatin—Asthenia—Methotrexate—urinary bladder cancer	7.12e-05	0.000477	CcSEcCtD
Pravastatin—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.08e-05	0.000475	CcSEcCtD
Pravastatin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.03e-05	0.000471	CcSEcCtD
Pravastatin—Pruritus—Methotrexate—urinary bladder cancer	7.02e-05	0.000471	CcSEcCtD
Pravastatin—Hypersensitivity—Epirubicin—urinary bladder cancer	6.84e-05	0.000459	CcSEcCtD
Pravastatin—Urticaria—Doxorubicin—urinary bladder cancer	6.83e-05	0.000458	CcSEcCtD
Pravastatin—Abdominal pain—Doxorubicin—urinary bladder cancer	6.79e-05	0.000455	CcSEcCtD
Pravastatin—Body temperature increased—Doxorubicin—urinary bladder cancer	6.79e-05	0.000455	CcSEcCtD
Pravastatin—Diarrhoea—Methotrexate—urinary bladder cancer	6.79e-05	0.000455	CcSEcCtD
Pravastatin—Asthenia—Epirubicin—urinary bladder cancer	6.66e-05	0.000447	CcSEcCtD
Pravastatin—Pruritus—Epirubicin—urinary bladder cancer	6.57e-05	0.00044	CcSEcCtD
Pravastatin—Dizziness—Methotrexate—urinary bladder cancer	6.56e-05	0.00044	CcSEcCtD
Pravastatin—Diarrhoea—Epirubicin—urinary bladder cancer	6.35e-05	0.000426	CcSEcCtD
Pravastatin—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.33e-05	0.000424	CcSEcCtD
Pravastatin—Vomiting—Methotrexate—urinary bladder cancer	6.31e-05	0.000423	CcSEcCtD
Pravastatin—Rash—Methotrexate—urinary bladder cancer	6.26e-05	0.000419	CcSEcCtD
Pravastatin—Dermatitis—Methotrexate—urinary bladder cancer	6.25e-05	0.000419	CcSEcCtD
Pravastatin—Headache—Methotrexate—urinary bladder cancer	6.22e-05	0.000417	CcSEcCtD
Pravastatin—Asthenia—Doxorubicin—urinary bladder cancer	6.17e-05	0.000413	CcSEcCtD
Pravastatin—Dizziness—Epirubicin—urinary bladder cancer	6.14e-05	0.000412	CcSEcCtD
Pravastatin—Pruritus—Doxorubicin—urinary bladder cancer	6.08e-05	0.000407	CcSEcCtD
Pravastatin—Vomiting—Epirubicin—urinary bladder cancer	5.9e-05	0.000396	CcSEcCtD
Pravastatin—Nausea—Methotrexate—urinary bladder cancer	5.89e-05	0.000395	CcSEcCtD
Pravastatin—Diarrhoea—Doxorubicin—urinary bladder cancer	5.88e-05	0.000394	CcSEcCtD
Pravastatin—Rash—Epirubicin—urinary bladder cancer	5.86e-05	0.000392	CcSEcCtD
Pravastatin—Dermatitis—Epirubicin—urinary bladder cancer	5.85e-05	0.000392	CcSEcCtD
Pravastatin—Headache—Epirubicin—urinary bladder cancer	5.82e-05	0.00039	CcSEcCtD
Pravastatin—Dizziness—Doxorubicin—urinary bladder cancer	5.68e-05	0.000381	CcSEcCtD
Pravastatin—Nausea—Epirubicin—urinary bladder cancer	5.52e-05	0.00037	CcSEcCtD
Pravastatin—Vomiting—Doxorubicin—urinary bladder cancer	5.46e-05	0.000366	CcSEcCtD
Pravastatin—Rash—Doxorubicin—urinary bladder cancer	5.42e-05	0.000363	CcSEcCtD
Pravastatin—Dermatitis—Doxorubicin—urinary bladder cancer	5.41e-05	0.000363	CcSEcCtD
Pravastatin—Headache—Doxorubicin—urinary bladder cancer	5.38e-05	0.000361	CcSEcCtD
Pravastatin—Nausea—Doxorubicin—urinary bladder cancer	5.1e-05	0.000342	CcSEcCtD
Pravastatin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.14e-05	0.000269	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	2.14e-05	0.000269	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.14e-05	0.000268	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.13e-05	0.000268	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.12e-05	0.000266	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.11e-05	0.000265	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.11e-05	0.000264	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	2.08e-05	0.000261	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—GSTP1—urinary bladder cancer	2.08e-05	0.000261	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.08e-05	0.000261	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.07e-05	0.00026	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	2.05e-05	0.000258	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ENO2—urinary bladder cancer	2.04e-05	0.000256	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—HPGDS—urinary bladder cancer	2.04e-05	0.000256	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—MTHFR—urinary bladder cancer	2.04e-05	0.000256	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	2.03e-05	0.000255	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	2.03e-05	0.000255	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—TYMP—urinary bladder cancer	2.02e-05	0.000254	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.02e-05	0.000253	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.01e-05	0.000252	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2e-05	0.000251	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—GSTT1—urinary bladder cancer	1.98e-05	0.000249	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	1.96e-05	0.000246	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	1.96e-05	0.000246	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	1.94e-05	0.000244	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	1.94e-05	0.000243	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—TYMS—urinary bladder cancer	1.93e-05	0.000242	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	1.91e-05	0.00024	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—TP53—urinary bladder cancer	1.91e-05	0.00024	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—GSTM1—urinary bladder cancer	1.91e-05	0.00024	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—NCOR1—urinary bladder cancer	1.91e-05	0.00024	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	1.91e-05	0.000239	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PPARG—urinary bladder cancer	1.89e-05	0.000238	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.87e-05	0.000235	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.86e-05	0.000233	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.85e-05	0.000232	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	1.83e-05	0.00023	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	1.83e-05	0.00023	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—GPX1—urinary bladder cancer	1.83e-05	0.00023	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—HRAS—urinary bladder cancer	1.83e-05	0.000229	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—CREBBP—urinary bladder cancer	1.82e-05	0.000228	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.81e-05	0.000227	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.8e-05	0.000226	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.8e-05	0.000226	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—ERCC2—urinary bladder cancer	1.8e-05	0.000225	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	1.79e-05	0.000225	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	1.79e-05	0.000224	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	1.78e-05	0.000223	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.76e-05	0.000221	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.76e-05	0.000221	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.75e-05	0.00022	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	1.73e-05	0.000218	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.73e-05	0.000217	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.72e-05	0.000216	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—MTHFR—urinary bladder cancer	1.69e-05	0.000212	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.68e-05	0.000211	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.68e-05	0.000211	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.67e-05	0.00021	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PPARG—urinary bladder cancer	1.65e-05	0.000208	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—NQO1—urinary bladder cancer	1.65e-05	0.000207	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.64e-05	0.000206	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	1.61e-05	0.000202	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	1.59e-05	0.0002	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	1.59e-05	0.0002	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—CREBBP—urinary bladder cancer	1.59e-05	0.000199	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NAT2—urinary bladder cancer	1.59e-05	0.000199	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.58e-05	0.000198	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.55e-05	0.000195	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.55e-05	0.000195	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.53e-05	0.000192	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	1.53e-05	0.000192	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.51e-05	0.000189	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.5e-05	0.000188	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	1.5e-05	0.000188	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PTGS2—urinary bladder cancer	1.49e-05	0.000187	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	1.48e-05	0.000186	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.47e-05	0.000184	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.46e-05	0.000184	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.46e-05	0.000184	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	1.45e-05	0.000183	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	1.44e-05	0.000181	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.44e-05	0.00018	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.43e-05	0.00018	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	1.43e-05	0.000179	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.42e-05	0.000178	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.42e-05	0.000178	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.41e-05	0.000177	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	1.4e-05	0.000175	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.4e-05	0.000175	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.39e-05	0.000174	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.38e-05	0.000173	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.38e-05	0.000173	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.37e-05	0.000172	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.37e-05	0.000172	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.37e-05	0.000172	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PPARG—urinary bladder cancer	1.37e-05	0.000172	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.36e-05	0.000171	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.36e-05	0.000171	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—CREBBP—urinary bladder cancer	1.31e-05	0.000165	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.31e-05	0.000164	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.3e-05	0.000163	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PTGS2—urinary bladder cancer	1.3e-05	0.000163	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PTEN—urinary bladder cancer	1.3e-05	0.000163	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.29e-05	0.000162	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000161	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.28e-05	0.000161	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.28e-05	0.00016	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.27e-05	0.000159	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.27e-05	0.000159	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.26e-05	0.000158	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.26e-05	0.000158	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.26e-05	0.000158	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—EP300—urinary bladder cancer	1.24e-05	0.000155	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.23e-05	0.000155	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.23e-05	0.000154	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.21e-05	0.000152	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.21e-05	0.000152	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.21e-05	0.000152	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.2e-05	0.000151	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.19e-05	0.00015	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.19e-05	0.000149	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.18e-05	0.000148	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.18e-05	0.000148	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	1.14e-05	0.000144	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.14e-05	0.000143	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PTEN—urinary bladder cancer	1.14e-05	0.000142	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.12e-05	0.000141	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.12e-05	0.00014	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.11e-05	0.00014	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.1e-05	0.000139	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.1e-05	0.000139	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	0.000138	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—EP300—urinary bladder cancer	1.08e-05	0.000136	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	0.000135	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.07e-05	0.000134	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.04e-05	0.000131	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.04e-05	0.000131	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.03e-05	0.00013	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.03e-05	0.00013	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.03e-05	0.000129	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.02e-05	0.000128	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.01e-05	0.000127	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1e-05	0.000126	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1e-05	0.000126	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	9.98e-06	0.000125	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.92e-06	0.000124	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.86e-06	0.000124	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	9.84e-06	0.000124	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	9.77e-06	0.000123	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—EP300—urinary bladder cancer	9.51e-06	0.000119	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	9.41e-06	0.000118	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PTEN—urinary bladder cancer	9.39e-06	0.000118	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	9.39e-06	0.000118	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	9.15e-06	0.000115	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PPARG—urinary bladder cancer	9.05e-06	0.000114	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	9.04e-06	0.000114	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	9.04e-06	0.000114	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	8.99e-06	0.000113	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—EP300—urinary bladder cancer	8.95e-06	0.000112	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NQO1—urinary bladder cancer	8.9e-06	0.000112	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CREBBP—urinary bladder cancer	8.69e-06	0.000109	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	8.66e-06	0.000109	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.65e-06	0.000109	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	8.53e-06	0.000107	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	8.51e-06	0.000107	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	8.5e-06	0.000107	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	8.39e-06	0.000105	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	8.32e-06	0.000104	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.25e-06	0.000104	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.07e-06	0.000101	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	7.99e-06	0.0001	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	7.93e-06	9.95e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	7.84e-06	9.84e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	7.83e-06	9.83e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	7.83e-06	9.83e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	7.69e-06	9.65e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	7.5e-06	9.42e-05	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—EP300—urinary bladder cancer	7.48e-06	9.38e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	7.43e-06	9.32e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	7.37e-06	9.24e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.35e-06	9.22e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PTGS2—urinary bladder cancer	7.12e-06	8.93e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.04e-06	8.83e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	7e-06	8.78e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	6.94e-06	8.71e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	6.92e-06	8.69e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—TYMS—urinary bladder cancer	6.9e-06	8.67e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	6.83e-06	8.57e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	6.83e-06	8.57e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	6.81e-06	8.54e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	6.81e-06	8.54e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.71e-06	8.42e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	6.7e-06	8.41e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	6.6e-06	8.28e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GPX1—urinary bladder cancer	6.54e-06	8.2e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	6.51e-06	8.17e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	6.48e-06	8.13e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	6.45e-06	8.1e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	6.43e-06	8.07e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	6.43e-06	8.07e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	6.42e-06	8.05e-05	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	6.39e-06	8.02e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	6.38e-06	8e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	6.38e-06	8e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	6.23e-06	7.81e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PTEN—urinary bladder cancer	6.21e-06	7.79e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	6.16e-06	7.73e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	6.11e-06	7.66e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	6.05e-06	7.59e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.03e-06	7.57e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	5.99e-06	7.52e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—EP300—urinary bladder cancer	5.92e-06	7.43e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.68e-06	7.13e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.63e-06	7.07e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	5.61e-06	7.05e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.49e-06	6.89e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	5.39e-06	6.77e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.1e-06	6.4e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PPARG—urinary bladder cancer	4.89e-06	6.14e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	4.7e-06	5.9e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.61e-06	5.78e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.58e-06	5.74e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.57e-06	5.73e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	4.45e-06	5.58e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.43e-06	5.56e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.42e-06	5.54e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.39e-06	5.51e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.25e-06	5.34e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.24e-06	5.32e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.2e-06	5.28e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.2e-06	5.28e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.03e-06	5.05e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.95e-06	4.96e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	3.85e-06	4.83e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	3.85e-06	4.83e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.72e-06	4.66e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—EP300—urinary bladder cancer	3.67e-06	4.61e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.63e-06	4.55e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.59e-06	4.51e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.36e-06	4.21e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—EP300—urinary bladder cancer	3.2e-06	4.02e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.16e-06	3.97e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.13e-06	3.93e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.02e-06	3.78e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.01e-06	3.78e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.99e-06	3.75e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.89e-06	3.63e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.37e-06	2.98e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.07e-06	2.59e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.97e-06	2.47e-05	CbGpPWpGaD
